Beijing Hanmi Pharm
Scope
Date
~
-
Bio & Pharma
Daewoong Pharm set to export Envlo Tab to Russia, CIS
Daewoong Pharmaceutical, a leading South Korean pharmaceutical company will export its new diabetes drug Envlo Tab. (active ingredient:enavogliflozi...
Dec 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Pharm gets GMP certification from Japan
Celltrion Pharm Inc. announced on Wednesday that its pre-filled syringe (PFS) production facility in Cheongju, North Chungcheong Province has obtain...
Sep 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Science joins race to develop Wegovy competitor
Hanmi Science Co., the holding company of South Korea’s pharmaceutical giant Hanmi Pharmaceutical Co., has joined the global race to develop t...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Yungjin Pharm's new drug candidate gets Fast Track from FDA
South Korea's Yungjin Pharm has secured Fast Track designation from the US Food and Drug Administration (FDA) for its new drug candidate KL1333, des...
Sep 06, 2023 (Gmt+09:00)
-
Korean chipmakers
Hanmi Semiconductor wins $31 mn order HBM equipment for SK Hynix
South Korean chip equipment company Hanmi Semiconductor Co. said on Friday that it has secured a 41.5 billion won ($31.4 million) deal with SK Hynix...
Sep 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to start global clinical trials for immune-oncology drug
South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...
Aug 22, 2023 (Gmt+09:00)
-
Korean stock market
MSCI Korea Index adds EcoPro, Hanwha Ocean, drops Emart
Four stocks, including EcoPro Co., have been added to the Morgan Stanley Capital International (MSCI) Korea Index, and two have been removed.MSCI, a...
Aug 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Dongwha Pharm to buy Vietnamese pharmacy chain at $30 mn
South Korea's Dongwha Pharm announced on Thursday that it signed an agreement to acquire a 51% stake in Trung Son Pharma, a leading pharmacy chain i...
Aug 04, 2023 (Gmt+09:00)
-
Korean chipmakers
Hanmi Semiconductor opens new bonder factory
South Korean chip equipment company Hanmi Semiconductor Co. said on Wednesday it has opened a new factory to boost the production of dual TC bonders...
Aug 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to develop obesity drug customized for S.Korean
South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., i...
Jul 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Daehwa Pharm applies for approval of anti-dementia patch in China
South Korea's Daehwa Pharm Co. is speeding up its advance into the Chinese market for anti-dementia medicine, applying for sales approval of its pat...
Jun 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm's Efinopegdutide gets Fast Track Designation from FDA
Merck, known as MSD outside the United States and Canada, announced on Monday that Efinopegdutide, a technology transferred from the South Korean ph...
Jun 13, 2023 (Gmt+09:00)
-
Electronics
Samsung unveils 2023 model TV, home appliances in China
Samsung Electronics Co. announced that it held the 2023 China Tech Seminar in Beijing, China, on Friday, unveiling the new TV and home appliance tec...
Jun 09, 2023 (Gmt+09:00)
-
Korean chipmakers
Hanmi Semiconductor sets up local corporation in Vietnam
South Korean chip equipment maker Hanmi Semiconductor Co. said on Wednesday that it has set up a local subsidiary, Hanmi Vietnam, in the Bac Ninh re...
May 31, 2023 (Gmt+09:00)
-
Machinery
Hanmi Semiconductor named world’s top 10 chip equipment maker
South Korean chip equipment maker Hanmi Semiconductor Co. on Thursday said it made the world’s top 10 in the rankings of TechInsights, a globa...
May 19, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's ST Pharm supplies $49 mn worth of APIs to European drug firm
ST Pharm Co., a South Korean pharmaceutical firm, announced on Thursday that it had entered into an agreement to supply oligonucleotides to an undis...
Mar 24, 2023 (Gmt+09:00)
-
Korean games
Will S.Korean games benefit from China’s deregulation?
China is loosening its grip on foreign online games with approvals on 27 titles, raising hopes that South Korean publishers will expand their presen...
Mar 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's ST Pharm completes new R&D hub for gene therapy
ST Pharm Co., a South Korean drug raw material-producing subsidiary of Dong-A Socio Holdings, said on Friday that it has finished building an R&...
Mar 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea United Pharm signs contract to supply medicines to Saudi Arabia
Korea United Pharm. Inc. announced on Monday that it signed a contract to supply nine types of medicines, including 11 anticancer drugs, to Saudi ph...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Brazil approves Celltrion Pharm’s syringe facility
Celltrion Pharm Inc., a South Korean biopharmaceutical company, said on Monday it received certification from Brazil’s health regulator for it...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharmaceutical reports record-high revenue in 2022
South Korea's Hanmi Pharmaceutical Co. last year saw record-high performance thanks to its self-developed drugs, surpassing its previous best year o...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US
South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
ST Pharm exports $14.6 mn worth of drug ingredients to Europe
ST Pharm Co., a South Korean company specializing in contract development and manufacturing of drug ingredients, has signed a supply contract worth ...
Jan 20, 2023 (Gmt+09:00)
-
Bio & Pharma
JVM to sell fully automated drug inspection machines in US
Hanmi Pharmaceutical Co. said on Monday that it had signed an agreement with Euclid Medical Products, a company specializing in manufacturing drug d...
Jan 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Samjin Pharm to undertake joint ADC R&D with Novelty Nobility
SamjinPharmaceutical announced Wednesday that it has signed a joint research agreement with Novelty Nobility Inc., a company specializing in antibod...
Jan 04, 2023 (Gmt+09:00)
-
Airlines
Korea-China air flights set to rise with Beijing’s eased zero-COVID policy
Air flights between South Korea and China are set to rise significantly next year with the Chinese government issuing new guidelines easing its stri...
Dec 22, 2022 (Gmt+09:00)
-
Korean stock market
KRX opens German office to promote EU certification of Korean indices
The Korea Exchange said that it opened its third overseas office in Frankfurt, Germany, and would promote the EU Benchmarks Regulation (BMR) certifi...
Dec 16, 2022 (Gmt+09:00)
-
Bio & Pharma
Spectrum to push back launch date of Hanmi-developed drug Poziotinib
Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...
Nov 25, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum
South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...
Sep 13, 2022 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand